anmelden
QIX Deutschland
17.280,36
PKT
+219,93
PKT
+1,29
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu QIX Deutschland-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.04.20 | Covestro Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.20 | Evonik Hold | HSBC | |
| 02.04.20 | Nemetschek Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.04.20 | SAP buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.04.20 | Hannover Rück Sector Perform | RBC Capital Markets | |
| 02.04.20 | RATIONAL Underperform | RBC Capital Markets | |
| 02.04.20 | freenet Halten | Independent Research GmbH | |
| 02.04.20 | RATIONAL buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.04.20 | Hannover Rück Underweight | Barclays Capital | |
| 02.04.20 | Bechtle Hold | Jefferies & Company Inc. | |
| 02.04.20 | CANCOM buy | Jefferies & Company Inc. | |
| 02.04.20 | Henkel vz. Neutral | Goldman Sachs Group Inc. | |
| 01.04.20 | Evonik buy | Baader Bank | |
| 01.04.20 | Covestro Halten | DZ BANK | |
| 01.04.20 | SAP Outperform | Bernstein Research | |
| 01.04.20 | Symrise Halten | Norddeutsche Landesbank (Nord/LB) | |
| 01.04.20 | Evonik Conviction Buy | Goldman Sachs Group Inc. | |
| 01.04.20 | Symrise buy | Goldman Sachs Group Inc. | |
| 01.04.20 | Covestro buy | Goldman Sachs Group Inc. | |
| 01.04.20 | Gerresheimer buy | Deutsche Bank AG | |
| 01.04.20 | adidas Halten | DZ BANK | |
| 01.04.20 | Nemetschek Equal weight | Barclays Capital | |
| 01.04.20 | Deutsche Börse Equal-Weight | Morgan Stanley | |
| 01.04.20 | Evonik Neutral | Credit Suisse Group | |
| 01.04.20 | Covestro Outperform | Credit Suisse Group | |
| 01.04.20 | Symrise Outperform | Credit Suisse Group | |
| 31.03.20 | Siemens Healthineers kaufen | DZ BANK | |
| 31.03.20 | FUCHS Halten | Independent Research GmbH | |
| 31.03.20 | Nemetschek Hold | Kepler Cheuvreux | |
| 31.03.20 | Siemens Healthineers Underweight | JP Morgan Chase & Co. | |
| 31.03.20 | Nemetschek Reduce | Baader Bank | |
| 31.03.20 | Nemetschek Equal weight | Barclays Capital | |
| 31.03.20 | Siemens Healthineers Outperform | Credit Suisse Group | |
| 31.03.20 | Siemens Healthineers neutral | Barclays Capital | |
| 30.03.20 | Hannover Rück Equal-Weight | Morgan Stanley | |
| 30.03.20 | Knorr-Bremse Hold | Kepler Cheuvreux | |
| 30.03.20 | Siemens Healthineers buy | Kepler Cheuvreux | |
| 30.03.20 | Knorr-Bremse Sell | Warburg Research | |
| 30.03.20 | Symrise market-perform | Bernstein Research | |
| 30.03.20 | Evonik Outperform | Bernstein Research |
